Navigation Links
Solazyme Announces New Senior Vice President of Business Development

Troy J. Campione, Ph.D., Joins Solazyme Executive Team

SOUTH SAN FRANCISCO, Calif., Oct. 3 /PRNewswire/ -- Solazyme, a bioscience company pioneering biofuels and health/wellness products from microalgae, has named Troy J. Campione, Ph.D., to the position of senior vice president of business development.

Campione will lead the development, negotiation, and finalization of partnership agreements and contracts with major companies. These deals will help fund research and development programs leveraging Solazyme's work on biofuels and industrial chemicals.

Campione has extensive experience monetizing technology across diverse industries and geographies. Most recently he was general manager and vice president of Symyx Technologies, Inc., a company providing high throughput research and informatics technologies globally to the chemical, energy, polymer, pharmaceutical, and electronics industries. At Symyx, he was accountable for collaborative research, strategic alliances, and materials licensing. During his tenure, Campione leveraged the company's technology position to negotiate more than $400 million of new research services, products, and licensing revenues with major chemical and energy companies including ExxonMobil, Dow Chemical, BP, Ineos, Innovene, and Celanese.

"Troy's breadth of experience in developing strategic alliances along with his talent for licensing technologies will enhance our ability to develop relationships with potential partners as we commercialize our algal-based technologies," said Jonathan Wolfson, president and chief operating officer of Solazyme. "We are extremely excited to have him join our management team."

Prior to Symyx, Campione spent 15 years at ExxonMobil in business, research and development, and technology management positions in Houston, Baytown, and Baton Rouge. He led the research and development activities for advanced catalyst and process technologies as worldwide basic chemicals technology manager, delivered continued success and growth of the vinyl intermediates area as its business manager, and prioritized, championed, and secured significant chemical plant expansions for the intermediates business of Exxon Chemical.

Campione earned his Ph.D. in chemical engineering from the University of Texas at Austin and also holds M.E. and B.S degrees in Chemical Engineering from Tulane University.

About Solazyme:

Founded in 2003 and headquartered in South San Francisco, California, Solazyme is a leading biotechnology company focused on the engineering and optimization of algae for production of biofuels and health and wellness materials. For more information, please visit our website:

For More Information Contact:

Jackie Kolek Ellen Snook

Peppercom Peppercom

212-931-6166 415-438-9821

SOURCE Solazyme
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Speaker announces business members of IT Task Force
2. Doyle announces technology tax credits for Berbee
3. Doyle announces new energy, global warming policies
4. Doyle announces $80M renewable energy strategy
5. GE announces first installation of Discovery VCT
6. UWM announces winners of RGI awards
7. Third Wave announces two senior management appointments
8. Mirus announces new method for making antibodies
9. Merge announces sofware updates, upcoming acquisition
10. Small Tree announces ethernet solution for Apple Xserv G5
11. TEKLYNX International announces new RFID software
Post Your Comments:
(Date:11/24/2015)... FRANCISCO , Nov. 24, 2015  Twist ... announced that Emily Leproust, Ph.D., Twist Bioscience chief ... Jaffray Healthcare Conference on December 1, 2015 at ... Hotel in New York City. --> ... . Twist Bioscience is on Twitter. ...
(Date:11/24/2015)... ... 24, 2015 , ... InSphero AG, the leading supplier of easy-to-use solutions for ... Aregger to serve as Chief Operating Officer. , Having joined InSphero in ... and was promoted to Head of InSphero Diagnostics in 2014. There she ...
(Date:11/24/2015)... , Nov. 24, 2015 /CNW Telbec/ - ProMetic Life Sciences ... today that Mr. Pierre Laurin , President and Chief ... at the upcoming Piper Jaffray 27 th Annual Healthcare ... on December 1-2, 2015. st , at ... one-on-one meetings throughout the day. The presentation will be available ...
(Date:11/24/2015)... , Nov. 24, 2015 HemoShear ... on discovering drugs for metabolic disorders, announced today ... to its Board of Directors (BOD). Mr. Watkins ... of Human Genome Sciences (HGS), and also served ... Jim Powers , Chairman and CEO ...
Breaking Biology Technology:
(Date:11/18/2015)... --> --> ... report titled  Gesture Recognition Market - Global Industry Analysis, ... to the report, the global gesture recognition market was valued at ... US$29.1 bn by 2021, at a CAGR of 20.3% ... dominated the global gesture recognition market in ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/12/2015)... -- A golden retriever that stayed healthy despite having the ... a new lead for treating this muscle-wasting disorder, report ... MIT and Harvard and the University of São Paolo ... Cell, pinpoints a protective gene that boosts muscle ... Boston Children,s lab of Lou Kunkel , PhD, ...
Breaking Biology News(10 mins):